DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Clinical trial NCT02197169 · COMPLETED
Trial details
- NCT number
- NCT02197169
- Sponsor
- DNAtrix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-11
- Primary completion
- 2018-03-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.